^
    Back
    Association details:
    Biomarker:EGFR L861Q
    Cancer:Small Cell Lung Cancer
    Drug:gefitinib (EGFR inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C4 – Case Studies
    New
    Source:
    Transl Cancer Res
    Title:

    A case report of pulmonary combined small cell carcinoma with enteric adenocarcinoma

    Excerpt:
    We report a case with both small cell lung cancer (SCLC) and enteric adenocarcinoma for the first time….Considering the epidermal growth factor receptor (EGFR) p.L861Q mutation, the patient received gefitinib and EP chemotherapy, and she responded well to the combination therapy.
    Secondary therapy:
    EP
    DOI:
    10.21037/tcr-22-1171